Live Breaking News & Updates on Dolma Outdoor Expedition

Stay updated with breaking news from Dolma outdoor expedition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Analysts Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Price Target at $21.00

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned an average recommendation of “Buy” from the seven research firms that are currently covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in the last […] ....

Sean Bohen , Cyrus Harmon , Olema Pharmaceuticals Stock Down , Virtu Financial , News Ratings For Olema Pharmaceuticals Daily , Royal Bank , Citigroup Inc , Olema Pharmaceuticals Inc , Hedge Funds Weigh In On Olema Pharmaceuticals , Analyst Recommendations For Olema Pharmaceuticals , Olema Pharmaceuticals , Balyasny Asset Management , Securities Exchange Commission , Get Free Report , Pharmaceuticals Stock Down , Exchange Commission , Director Cyrus Harmon , Street Group , Asset Management , Get Free , Olema Pharmaceuticals Daily , Nasdaq Olma ,

Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Citigroup

Analysts at Citigroup started coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report) in a report released on Tuesday, Marketbeat reports. The firm set a “buy” rating and a $20.00 price target on the stock. Citigroup’s price target points to a potential upside of 72.12% from the company’s current price. Separately, HC Wainwright […] ....

Cyrus Harmon , Davidc Myles , Olema Pharmaceuticals Stock , Analyst Recommendations For Olema Pharmaceuticals , News Ratings For Olema Pharmaceuticals Daily , Vivo Capital , Olema Pharmaceuticals Company Profile , Institutional Investors Weigh In On Olema Pharmaceuticals , Securities Exchange Commission , Dimensional Fund Advisors , Olema Pharmaceuticals Inc , Vanguard Group Inc , Olema Pharmaceuticals , Blackrock Inc , Get Free Report , Director Cyrus Harmon , Exchange Commission , Fund Advisors , Olema Pharmaceuticals Daily , Nasdaq Olma , Initiated Coverage , Citigroup Inc ,

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives $21.20 Average Target Price from Brokerages

Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) have been assigned a consensus rating of “Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have updated their coverage on […] ....

Cyrus Harmon , Sean Bohen , Olema Pharmaceuticals Inc , Royal Bank , Securities Exchange Commission , Virtu Financial , News Ratings For Olema Pharmaceuticals Daily , Analyst Recommendations For Olema Pharmaceuticals , Jpmorgan Chase Co , Balyasny Asset Management , Citigroup Inc , Olema Pharmaceuticals , Olema Pharmaceuticals Stock Down , Get Free Report , Exchange Commission , Director Cyrus Harmon , Street Group , Asset Management , Pharmaceuticals Stock Down , Get Free , Olema Pharmaceuticals Daily , Nasdaq Olma ,